Allogeneic vs. autologous transplant

Allogeneic transplant can treat diseases an autologous transplant cannot, because the new donor immune system can attack remaining cancer cells — but it carries donor-match and graft-versus-host-disease risk. Autologous transplant avoids donor-match risk entirely but depends on the patient's own cells being disease-free enough to use.

← Back to the full glossary